Whalen Wealth Management’s Colgate-Palmolive CL Stock Holding History

Whalen Wealth Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,200	Closed	-$291K	–	129
2024 Q4	$291K	Buy	+3,200	New	+$305K	0.2%	97

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Whalen Wealth Management's CL Position: Q1 2025 in Review

Whalen Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 3,200 shares — an estimated $291K sold.

Whalen Wealth Management first reported a position in CL in Q4 2024 and held it in 1 quarter. The position peaked at $291K in Q4 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Whalen Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
Whalen Wealth Management sold 3,200 Colgate-Palmolive shares in Q1 2025, an estimated $291K.
Whalen Wealth Management first reported a position in Colgate-Palmolive in Q4 2024 and held it in 1 quarter.
Whalen Wealth Management's Colgate-Palmolive position peaked at $291K in Q4 2024.
1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Whalen Wealth Management's 13F filing for Q1 2025, filed 22 Apr 2025.